160 related articles for article (PubMed ID: 20170280)
1. Comparative renal excretion of VX-702, a novel p38 MAPK inhibitor, and methotrexate in the perfused rat kidney model.
Tamhane M; Chakilam AR; Jayaraj A; Thakkar V; Taft DR
Drug Dev Ind Pharm; 2010 Mar; 36(3):315-22. PubMed ID: 20170280
[TBL] [Abstract][Full Text] [Related]
2. Possible involvement of organic anion and cation transporters in renal excretion of xanthine derivatives, 3-methylxanthine and enprofylline.
Nadai M; Kato M; Yoshizumi H; Kimura M; Kurono S; Abe F; Saito H; Hasegawa T
Life Sci; 2007 Sep; 81(15):1175-82. PubMed ID: 17897683
[TBL] [Abstract][Full Text] [Related]
3. Renal excretion of clofarabine: assessment of dose-linearity and role of renal transport systems on drug excretion.
Ajavon AD; Bonate PL; Taft DR
Eur J Pharm Sci; 2010 Jun; 40(3):209-16. PubMed ID: 20347037
[TBL] [Abstract][Full Text] [Related]
4. Characterization of methotrexate elimination and interaction with indomethacin and flurbiprofen in the isolated perfused rat kidney.
Statkevich P; Fournier DJ; Sweeney KR
J Pharmacol Exp Ther; 1993 Jun; 265(3):1118-24. PubMed ID: 8509997
[TBL] [Abstract][Full Text] [Related]
5. A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters.
Tahara H; Kusuhara H; Endou H; Koepsell H; Imaoka T; Fuse E; Sugiyama Y
J Pharmacol Exp Ther; 2005 Oct; 315(1):337-45. PubMed ID: 16006492
[TBL] [Abstract][Full Text] [Related]
6. Characterization of pentamidine excretion in the isolated perfused rat kidney.
Poola NR; Kalis M; Plakogiannis FM; Taft DR
J Antimicrob Chemother; 2003 Sep; 52(3):397-404. PubMed ID: 12888599
[TBL] [Abstract][Full Text] [Related]
7. Effect of H2 antagonists on the differential secretion of triamterene and its sulfate conjugate metabolite by the isolated perfused rat kidney.
Muirhead MR; Somogyi AA
Drug Metab Dispos; 1991; 19(2):312-6. PubMed ID: 1676629
[TBL] [Abstract][Full Text] [Related]
8. Quantitative evaluation of the drug-drug interactions between methotrexate and nonsteroidal anti-inflammatory drugs in the renal uptake process based on the contribution of organic anion transporters and reduced folate carrier.
Nozaki Y; Kusuhara H; Endou H; Sugiyama Y
J Pharmacol Exp Ther; 2004 Apr; 309(1):226-34. PubMed ID: 14722319
[TBL] [Abstract][Full Text] [Related]
9. Effects of probenecid and cimetidine on the renal excretion of 3'-azido-3'-deoxythymidine in rats.
Aiba T; Sakurai Y; Tsukada S; Koizumi T
J Pharmacol Exp Ther; 1995 Jan; 272(1):94-9. PubMed ID: 7815370
[TBL] [Abstract][Full Text] [Related]
10. Kinetic studies on the competition between famotidine and cimetidine in rats. Evidence of multiple renal secretory systems for organic cations.
Lin JH; Los LE; Ulm EH; Duggan DE
Drug Metab Dispos; 1988; 16(1):52-6. PubMed ID: 2894955
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of renal tubular transport of methotrexate by probenecid.
Bourke RS; Chheda G; Bremer A; Watanabe O; Tower DB
Cancer Res; 1975 Jan; 35(1):110-6. PubMed ID: 1109785
[TBL] [Abstract][Full Text] [Related]
12. Is the monkey an appropriate animal model to examine drug-drug interactions involving renal clearance? Effect of probenecid on the renal elimination of H2 receptor antagonists.
Tahara H; Kusuhara H; Chida M; Fuse E; Sugiyama Y
J Pharmacol Exp Ther; 2006 Mar; 316(3):1187-94. PubMed ID: 16291876
[TBL] [Abstract][Full Text] [Related]
13. Effect of cimetidine and probenecid on pilsicainide renal clearance in humans.
Shiga T; Hashiguchi M; Urae A; Kasanuki H; Rikihisa T
Clin Pharmacol Ther; 2000 Mar; 67(3):222-8. PubMed ID: 10741624
[TBL] [Abstract][Full Text] [Related]
14. Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis.
Beringer PM; Kriengkauykiat J; Zhang X; Hidayat L; Liu S; Louie S; Synold T; Burckart GJ; Rao PA; Shapiro B; Gill M
Pharmacotherapy; 2008 Jul; 28(7):883-94. PubMed ID: 18576903
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate-bestatin interaction: involvement of P-glycoprotein and organic anion transporters in rats.
Zhu Y; Meng Q; Wang C; Liu Q; Huo X; Zhang A; Sun P; Sun H; Li H; Liu K
Int J Pharm; 2014 Apr; 465(1-2):368-77. PubMed ID: 24530518
[TBL] [Abstract][Full Text] [Related]
16. Effects of trimethoprim on the clearance of apricitabine, a deoxycytidine analog reverse transcriptase inhibitor, and Lamivudine in the isolated perfused rat kidney.
Nakatani-Freshwater T; Babayeva M; Dontabhaktuni A; Taft DR
J Pharmacol Exp Ther; 2006 Nov; 319(2):941-7. PubMed ID: 16926264
[TBL] [Abstract][Full Text] [Related]
17. Effect of ketoprofen and its enantiomers on the renal disposition of methotrexate in the isolated perfused rat kidney.
Karpf DM; Kirkegaard AL; Evans AM; Nation RL; Hayball PJ; Milne RW
J Pharm Pharmacol; 2003 Dec; 55(12):1641-6. PubMed ID: 14738590
[TBL] [Abstract][Full Text] [Related]
18. Interactions between cimetidine, nitrofurantoin, and probenecid active transport into rat milk.
Gerk PM; Oo CY; Paxton EW; Moscow JA; McNamara PJ
J Pharmacol Exp Ther; 2001 Jan; 296(1):175-80. PubMed ID: 11123378
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of biliary excretion of methotrexate by probenecid in rats: quantitative prediction of interaction from in vitro data.
Ueda K; Kato Y; Komatsu K; Sugiyama Y
J Pharmacol Exp Ther; 2001 Jun; 297(3):1036-43. PubMed ID: 11356926
[TBL] [Abstract][Full Text] [Related]
20. Renal tubular transport of cimetidine in the isolated perfused kidney of the rat.
Boom SP; Moons MM; Russel FG
Drug Metab Dispos; 1994; 22(1):148-53. PubMed ID: 8149875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]